{
    "clinical_study": {
        "@rank": "46914", 
        "arm_group": [
            {
                "arm_group_label": "A, Conventional treatment", 
                "arm_group_type": "Other", 
                "description": "Operation + 8 cycles of adjuvant chemotherapy, if indicated."
            }, 
            {
                "arm_group_label": "B, Neoadjuvant chemotherapy", 
                "arm_group_type": "Other", 
                "description": "3 cycles of neoadjuvant chemotherapy + operation. Adjuvant chemotherapy only if indicated."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare 3 cycles of neoadjuvant (preoperative) chemotherapy\n      + operation with the standard treatment of locally advanced colon cancer, which is operation\n      + 8 cycles of (adjuvant) chemotherapy.\n\n      Patients receiving neoadjuvant chemotherapy may not need adjuvant chemotherapy after the\n      operation and, if this is the case, they will be spared of 5 cycles of chemotherapy."
        }, 
        "brief_title": "Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer", 
        "completion_date": {
            "#text": "August 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Colon Cancer", 
        "condition_browse": {
            "mesh_term": "Colonic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically verified locally advanced T3 (ETI > 5 mm) or T4 colon cancer assessed\n             by CT scan.\n\n          -  Age \u2265 18 years\n\n          -  PS 0-2.\n\n          -  Hematology ANC \u22651.5x10^9/l. Thrombocytes \u2265 100x10^9/l.\n\n          -  Biochemistry Bilirubinemia \u2264 3 x upper normal level. ALAT \u2264 5 x upper normal value\n\n          -  Consent to translational research\n\n          -  Fertile women must present a negative pregnancy test and use secure contraceptives\n             during and 3 months after treatment.\n\n          -  Written and orally informed consent.\n\n        Exclusion Criteria:\n\n          -  Patients with distant metastases.\n\n          -  Acute operation\n\n          -  Clinically significant cardiovascular disease (incl. myocardial infarction, unstable\n             angina, symptomatic congestive heart failure, serious uncontrolled cardiac\n             arrhythmia) \u2264 1 year before inclusion.\n\n          -  Active, serious infection or other serious disease.\n\n          -  Peripheral neuropathy NCI grade > 1\n\n          -  Other malignant disease within 5 years prior to study enrollment, except basocellular\n             or squamous skin cancer and carcinoma in situ cervicis uteri.\n\n          -  Other investigational treatment within 30 days prior to treatment start.\n\n          -  Hypersensitivity to one or more of the active or auxiliary substances."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01918527", 
            "org_study_id": "NeoCol"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "A, Conventional treatment", 
                    "B, Neoadjuvant chemotherapy"
                ], 
                "description": "Orally on days 1-14:\t2000 mg/m2/day q3w", 
                "intervention_name": "Capecitabine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "A, Conventional treatment", 
                    "B, Neoadjuvant chemotherapy"
                ], 
                "description": "Intravenously on day 1:\t130 mg/m2 q3w", 
                "intervention_name": "Oxaliplatin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Oxaliplatin", 
                "Capecitabine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Locally advanced colon cancer", 
            "Neoadjuvant chemotherapy"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "location": [
            {
                "contact": {
                    "email": "kell.oesterlind@regionh.dk", 
                    "last_name": "Kell Oesterlind, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark"
                    }, 
                    "name": "Rigshospitalet"
                }, 
                "investigator": {
                    "last_name": "Kell Oesterlinn, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark"
                    }, 
                    "name": "Hvidovre Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark"
                    }, 
                    "name": "Bispebjerg Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ole.larsen@regionh.dk", 
                    "last_name": "Ole Larsen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Herlev", 
                        "country": "Denmark"
                    }, 
                    "name": "Herlev Hospital"
                }, 
                "investigator": {
                    "last_name": "Ole Larsen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fahimeh.andersen@regionh.dk", 
                    "last_name": "Fahimeh Andersen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Hiller\u00f8d", 
                        "country": "Denmark"
                    }, 
                    "name": "Hilleroed Hospital"
                }, 
                "investigator": {
                    "last_name": "Fahimeh Andersen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "JSLA@regionsjaelland.dk", 
                    "last_name": "Jim S Larsen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Roskilde", 
                        "country": "Denmark"
                    }, 
                    "name": "Roskilde Hospital"
                }, 
                "investigator": {
                    "last_name": "Jim S Larsen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "anders.jakobsen@rsyd.dk", 
                    "last_name": "Anders Jakobsen, DMSc"
                }, 
                "contact_backup": {
                    "email": "lars.henrik.jensen@rsyd.dk", 
                    "last_name": "Henrik Jensen, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Vejle", 
                        "country": "Denmark"
                    }, 
                    "name": "Vejle Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Henrik Jensen, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "John Ploen, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "olav.dahl@helse-bergen.no", 
                    "last_name": "Olav Dahl, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bergen", 
                        "country": "Norway"
                    }, 
                    "name": "Haukeland University Hospital"
                }, 
                "investigator": {
                    "last_name": "Olav Dahl, Professor, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "UXBRNM@ous-hf.no", 
                    "last_name": "Morgen Braendengen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway"
                    }, 
                    "name": "Oslo University Hospital"
                }, 
                "investigator": {
                    "last_name": "Morten Braendengen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "goran.u.carlsson@vgregion.se", 
                    "last_name": "G\u00f6ran Carlssen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Gothenburg", 
                        "country": "Sweden"
                    }, 
                    "name": "Sahlgrenska University Hospital"
                }, 
                "investigator": {
                    "last_name": "G\u00f6ran Carlsson, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Denmark", 
                "Norway", 
                "Sweden"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer", 
        "overall_official": [
            {
                "affiliation": "Vejle Hospital, Vejle, Denmark", 
                "last_name": "Anders Jakobsen, DMSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Vejle Hospital, Vejle, Denmark", 
                "last_name": "Henrik Jensen, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Haukeland University Hospital, Bergen, Norway", 
                "last_name": "Olav Dahl, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sahlgrenska University Hospital, Gothenburg, Sweden", 
                "last_name": "G\u00f6ran Carlsson, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: National Board of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Two-year disease free survival", 
            "safety_issue": "No", 
            "time_frame": "2 years after completed study treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01918527"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Rate of patients fulfilling the criteria for adjuvant chemotherapy", 
            "safety_issue": "Yes", 
            "time_frame": "6, 12, 18, and 24 months after completed study treatment"
        }, 
        "source": "Vejle Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vejle Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}